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ABSTRACT - Background: MTUYH and OGG1 genes have importance in the base excision repair 
systems of oxidized DNA bases. Modification of the tissue expression of these genes is related 
to the increased risk of developing colorectal cancer. Aim: To evaluate the tissue expression 
of MUTYH and OGG1 comparing normal and neoplastic tissues of patients with sporadic 
colorectal cancer and to correlate it with clinical and histopathological variables. Method: 
MUTYH and OGG1 tissue expression was quantified by RT-PCR in patients with colorectal 
cancer and the values were compared in normal and neoplastic tissues. MUTYH and OGG1 
expression was measured and normalized to the constitutive 18S gene. The level of expression 
of both genes was correlated with the variables: age, gender, tumor location, size of the 
tumor, histological type, degree of cell differentiation, invasion depth in the intestinal wall, 
angiolymphatic infiltration, lymph node involvement and TNM staging. Results: Was found 
downregulation of both genes in neoplastic when compared to normal tissue. There was 
downregulation of the MUTYH in larger tumors and in patients with angiolymphatic invasion. 
Tumors with more advanced TNM stages (III and IV) presented downregulation of both genes 
when compared to those with earlier stages (I and II). Conclusion: The MUTYH and OGG1 
genes present downregulation in the more advanced stages of colorectal cancer.
RESUMO - Racional: Os genes MUTYH e OGG1 possuem importância nos sistemas de reparo por 
excisão de bases oxidadas do DNA. Modificação na expressão tecidual desses genes encontra-
se relacionada ao maior risco do desenvolvimento do câncer colorretal. Objetivo: Avaliar a 
expressão tecidual dos genes MUTYH e OGG1 comparando tecidos normais e neoplásicos 
de portadores de câncer colorretal esporádico e correlacioná-la com variáveis clínicas 
e histopatológicas. Método: Avaliou-se por PCR, em tempo real, a expressão tecidual dos 
genes MUTYH e OGG1 em 49 portadores de câncer colorretal comparando tecidos normais 
e neoplásicos. A expressão dos genes MUTYH e OGG1 foi quantificada e normalizada com 
o gene constitutivo 18S. A intensidade de expressão de ambos os genes foi correlacionada 
as variáveis: idade, gênero, localização do tumor, tamanho do tumor, tipo histológico, 
grau de diferenciação celular, profundidade de invasão na parede intestinal, invasão 
angiolinfática, linfonodos comprometidos e estadiamento TNM. Resultados: Encontrou-se 
menor expressão de ambos os genes no tecido neoplásico quando comparado ao tecido 
normal. Houve menor expressão do gene MUTYH nos tumores com maiores dimensões e 
nos doentes que apresentavam invasão angiolinfática. Tumores com estadios mais avançados 
(III e IV) apresentavam expressão menor de ambos os genes quando comparados àqueles 
com estadios mais precoces (I e II). Conclusão: Os genes MUTYH e OGG1 apresentam menor 
expressão tecidual nos estadios mais avançados do câncer colorretal.
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According to recent epidemiological inquiry, colorectal cancer (CRC) occurred in 2015, 1.4 million people worldwide being the third type of most common malignant neoplasm among men and the second among women9. The National 
Institute of Cancer (INCA) estimates that for the biennium 2016-2017 In Brazil, depending 
on the geographical region considered, the CRC can affect of 3.35 to 28,15/100,000 
inhabitants among men and 2.09 to 29,13/100,000 inhabitants among women13. With 
the increase in life expectancy, the phenomena of globalisation at greater exposure to 
carcinogenic agents and, especially, the change of dietary habits it is expected that the 
CRC has increasing importance in the profile of mortality from cancer throughout the 
world considerably increasing the economic and social costs19,23. 
Genetic studies have shown development of sporadic CRC is an evolutionary process 
that involves a series of sequential mutations or modifications in the expression of genes 
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related to cell cycle21. It is already well established that the 
development of the CRC from the normal mucosa, is mediated 
by a sequence of mutations of genes controllers of cell cycle 
(the proliferation, differentiation, apoptosis and DNA repair)8,30. 
Mutations in these genes can confer additional advantages for 
growth of tumor tissue in relation to normal tissue19. 
Although the initial phenomena of colorectal carcinogenesis 
are still a reason for constant research, it has been demonstrated 
that DNA damage caused by reactive oxygen species (ROS) 
is related to the development of CRC34,27,31,20,4. The ROS are 
produced in large quantities in chronic inflammatory processes 
affecting the intestinal epithelium. These radicals induce 
persistent damage to DNA and, if they are not readily inhibited 
by antioxidant systems can cause mutations related to the 
development of the CRC16. One of the mechanisms of DNA 
damage to more well-studied relates to the oxidation of 
the base fertilization guanine, forming the 8-oxoguanina (8-
oxoG). The 8-oxoG is a highly oxidized mutagenic capable of 
causing transversions of CC→TA tapes of DNA allowing, if not 
repaired, the appearance of mutations. When these mutations 
compromise tumor suppressor genes or oncogenes may arise 
a clone of cells with proliferative autonomy and uncontrolled 
growth, changes inherent to the neoplastic cells31.
It is already well established that the oxidation of bases of 
DNA allows for the development of the CRC and that removal 
of these databases oxidized is vital to avoid the appearance of 
mutations26. A chronic imbalance between the mechanisms of 
damage and DNA repair increases the risk of genomic instability 
and, therefore, it is important to understand the mechanisms 
by which the repair systems that remove the oxidized bases of 
DNA present in the genome. For both, living organisms have 
specific genes to correct the errors of matching caused by 
oxidative stress. The system of excision of bases (BER) is the 
primary way to repair DNA responsible for correction of oxidized 
bases, having a fundamental role in preserving the integrity of 
the DNA submitted to the deleterious action of ROS28,24. Among 
all the genes involved in repairing and removing the 8-oxoG, 
genes MUTHY and OGG1, components of the system BER, 
have a prominent role. These genes encode DNA-glicosilases 
which has the function of removing the oxidized bases paired 
erroneously, ensuring the maintenance of the integrity of the 
tapes of DNA. Recent studies suggest that patients with CRC 
have lower expression of genes OGG1 and mutyh in tissue 
cancer when compared to normal tissues suggesting that 
these systems operate without a disability33. However, the 
correlation between the level of tissue expression and clinical 
variables and histopathological were still little studied33. The 
objective of this study was to evaluate the tissue expression 
of genes MUTYH and OGG1 in normal tissue and neoplastic 
patients with CRC sporadic and correlate it to the main clinical 
and histopathological.
METHOD
This study was submitted to and approved by the 
Research Ethics Committee at the Universidade São Francisco in 
Bragança Paulista (Project No. 0235.0.142.000-07). All patients 
who have provided biological material for the present study 
signed an informed consent form agreeing to participate in 
all stages, and were informed of the purpose of the research.
Casuistry
Were studied prospectively 49 patients being 26 (53%) 
women with an average age of 65.8±11.3 years, suffering 
from adenocarcinoma of the colon and rectum, surgery 
with curative intent. Were excluded by means of criteria of 
clinical and endoscopic patients suspected of hereditary 
CRC (adenomatous polyposis familial syndrome and Lynch), 
sick undergoing treatment neoadjuvant chemoradiation 
therapy, patients with CRC associated with inflammatory 
bowel disease, less than 18 years, sick submitted to surgical 
treatment in urgent circumstances, and those who refused to 
participate in the study. The patients selected for the study 
were submitted to clinical staging, laboratory and imaging 
examinations in accordance with the guidelines recommended 
by the American Society of Colorectal Surgeons5. 
Sample collection 
Immediately after the removal of the surgical specimen 
were collected fragments of tissue obtained from the mucosa 
normal colic (at least 10 cm from the proximal margin of 
the lesion), and the periphery of the neoplastic lesion. After 
collection, the fragments were identified with the record of 
the patient name, date and place of where they had been 
collected. The fragments were placed in tubes suitable for 
storage in ultra-cooling and immediately stored at -80° 
C until the time of processing. The data, epidemiological, 
clinical and pathological findings were obtained from medical 
records. Histopathological data such as location of the tumor, 
macroscopic aspect of the tumor, lesion size, histological 
type, degree of cellular differentiation, depth of invasion 
in the intestinal wall, presence of lymphatic invasion or 
perineural, number of lymph nodes resected, number of 
lymph nodes involved, reason of lymph nodes involved and 
staging TNM were extracted from the histopathological 
report prepared by a single pathologist with expertise in 
colorectal neoplasia. The staging of tumors followed the 
TNM Classification according to the 6th edition proposed by 
the UICC (International Union of Cancer Control). All the sick 
were treated at the outpatient clinic of a colorectal neoplasia 
of Hospital Universitário São Francisco, Bragança Paulista, 
SP, Brazil, by the same professional.
Extraction of RNA and RT-PCR (Real-time polymerase 
chain reaction)
Total RNA was isolated using the kit of tissue RNeasy 
(Qiagen). The purity was assessed using the NanoDrop 2000 
spectrophotometer (Thermo Scientific, Wilmington, DE, USA). 
The single strand of cDNA was synthesized from RNA using 
the kit for high capacity storage of cDNA (Applied Biosystems, 
Foster City, CA, USA) following the manufacturer’s protocol. 
Quantitative PCR was performed using a system of 
7500 real time PCR (Applied Biosystems) using the numbers 
of cycles limit determined by the software RQ Study (Applied 
Biosystems). The reactions were racing in triplicate, and the 
numbers of cycle threshold were considered by the average. 
The mixture of the reaction containing a total of e 50µl It 
was prepared as follows: 25 µl SYBR Green™, PCR SuperMix 
UDG (Invitrogen Life Technologies, Alemeda, CA, EUA), 10 
mM for each primer (Table 1), e 1 µl de cDNA (100 ng). The 
first cycle was performed with a preliminary treatment with 
UDG for 2 min at 50° C and denaturation by more 2 min to 
95° C, followed by 45 cycles of denaturation at 95° C for 15s, 
annealing at 60º C for 15 s and extension of the primer at 
72º C during 15 s. This step was followed by an analysis of 
melting points of amplification products of dual tape consisting 
of 40 cycles of 1° C decreased (15 s each) starting at 95° C. 
The first derivative of this map, dF/dT, represents the rate of 
change of fluorescence in the reaction. A significant change 
in the fluorescence occurs at the point of fusion of free dual 
chain found in the PCR. A map of dF/dT as a function of 
temperature shows these changes as distinct peaks.
The expression of genes MUTYH and OGG1 expression 
was measured and normalized for the gene incorporation 
18S, which showed a constant expression in all samples 
tested. The expression on was calculated according to the 
formula 2 (-∆∆Ct). And the results were expressed as mean of 
expression of the gene ±EP
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Were performed using statistical software version 13.0 SPSS 
(SPSS, Chicago, IL). The values found for the expression of the 
genes in the normal tissues and in the considered variables were 
identified by descriptive statistics and expressed as the average 
expression of the gene with its respective standard error. The 
comparison of the gene expression between the normal and 
neoscopic tissues, as well as between the proposed variables 
was performed using the parametric Mann-Whitney test. Values 
of p≤0.05 were significant values obtained in the comparison 
between normal and neoplastic tissues were identified with a cross 
(†), while the values obtained comparing the stratifications between 
the clinical and histopathological variables with an asterisk (*).
RESULTS
Population of patients
Table 2 shows the distribution of the sample in relation 
to the variables considered in the study.
TABLE 2 - Relationship of the variables studied
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20/49 (41%)
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Table 3 shows the expression of genes MUTYH and OGG1 
with respect to the characteristics of the studied samples, as 
well as between the normal tissue and neoplastic, considering 
only the variables where there was a statistically significant 
difference in one of the genes.
TABLE 3 - Gene expression OGG1 and MUTH according to the 


























† = p < 0.05 When compared to normal tissue; ** p < 0.05 When comparing the 
characteristics
DISCUSSION
The human genome is particularly vulnerable to oxidative 
stress. The ROS in the cells of the mucosa colic are formed 
as products of the normal aerobic metabolism or as a result 
of exposure of the cells to ionizing radiation, chemicals, 
ischemia, inflammation acute and chronic or, even, for the 
simple modification in the supply of energy substrate to normal 
colonocites represented by short-chain fatty acids20, 12. As they 
are electrophilic molecules with the ability highly reactive, 
ROS attack substances with high electron density such as the 
nitrogenous bases that make up DNA3. These radicals can cause 
breakage single or double quote in the tapes of the DNA or 
oxidize their nitrogenous bases allowing for the development 
of errors of matching and, consequently, the development 
of mutations7,2. When we consider the environmental factors 
related to the development of the CRC, studies have shown 
that oxidative stress is one of the main mechanisms responsible 
for the appearance of mutations related to the development 
of the disease6,2. It has been demonstrated that the chronic 
inflammation and continuously in the intestinal mucosa, as 
occurs in the intestinal inflammatory diseases, increasing the 
production of ROS, increases the possibility of developing of 
CRC31. Further strengthens this possibility the results of studies 
showing that the levels of oxidative stress in the neoplastic tissue 
of patients with CRC is significantly higher when compared to 
the normal tissue26,27.  
The oxidative damage most often caused in the DNA by 
exposure to the RLO is the formation of 8-oxoG. The neoplastic 
tissue of patients with CRC has on average two times more 
8-oxoG when compared to normal mucous17.
In order to correct the errors of matching caused by 
8-oxoG and prevent the emergence of mutations, the body has 
different systems of DNA repair. The system BER is the main 
responsible for excision of oxidized bases22. The genes MUTYH, 
OGG1, MTH1, NEIL1, APEX1, PARP1, LIG3, MGP e NTHL1 are 
the main components of the system BER. 
The genes MUTYH It is located on the short arm of 
chromosome 1 (1p32-34) and has 16 exons. Encodes a DNA-
ung formed by 535 amino acids with a molecular weight of 39 
kD, called MUTHY ung that operates in the DNA-glycosylase 
repair by excision of bases. During DNA duplication, the adenine 
base was usually matched to thymine (A-T), while guanine 
matched with the cytosine (C-G). During normal cellular aerobic 
metabolism or in situations that cause the increase of ROS 
production, the oxidation of guanine can occur to 8-oxoG. This 
oxidized base matched quickly and erroneously with adenine 
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instead of cytosine. MUTY-glycosylase acts by removing from 
the DNA strand adenine bases poorly coupled with 8-oxoG. The 
enzyme corrects this error so that the development of mutations 
by type G:C>T:A which can lead to tumor formation if they 
compromise cell cycle controlling genes. The importance of 
mutations in the MUTYH gene in colorectal carcinogenesis was 
highlighted by the Al-Tassan et al. In 2002, where the authors 
demonstrated for the first time, individuals from the same family 
who presented biallelic germline mutations in the MUTYH gene 
and who had recessive forms of familial adenomatous polyposis 
(FAP), associated with the development of colorectal adenomas 
presenting progression to CRC in age when compared to the 
classic forms of FAP1. When analyzing the neoplastic tissues of 
these patients they found a high index of transversions of the 
type G:C>T:A  in commonly mutated genes in the CRC (APC e 
K-RAS). Later, other authors confirmed these findings showing 
that mutations in the MUTYH gene, reducing the effectiveness 
of the BER system, predisposes to the appearance of CRC1,14,15.
The OGG1 gene is located on the short arm of the 
chromosome 3 (3p25.3). It consists of 12 exons and encodes 
the enzyme 8-oxoguanine glycosylase. It is estimated that the 
enzyme contains 424 amino acids in its molecule and molecular 
weight of 47kD25. It was demonstrated that the gene OGG1 
has an essential role in repairing BER correcting transversions 
G:C>T:A. The enzyme transcribed, promotes the hydroxylation 
of connections glicofílicas formed between the 8-oxoG and 
the fraction of sugar from the basis of fertilization, removing 
the molecule of 8-oxoG and forming a site apurinic on tape 
of DNA that after the excision is subsequently filled with the 
correct fertilization. By its fundamental role in the system BER, 
mutation and polymorphisms in the gene OGG1 are considered 
events that increase the susceptibility to various forms of cancer. 
Studies have shown that reducing the activity of the gene could 
contribute to the development of CRC32.
A considerable number of hereditary CRC shows genetic 
or epigenetic genes defects on the system repair. The possibility 
that also occur changes in the system BER in the CRC sporadically 
is a plausible hypothesis. So, the research profile of expression 
of genes of the system BER related to correction of oxidized 
bases comparing normal tissue and neoplastic, can improve 
the understanding of the role of these genes in patients with 
sporadic CRC32. Previous studies have demonstrated that there 
is less efficiency of the system BER in patients with CRC when 
compared to healthy volunteers15,33. However, the mutations 
of the MUTYH gene and OGG1 in patients with sporadic 
CRC are not frequent and are influenced by the ethnic group 
studied14,15,33. Thus, in order to evaluate the mutations in these 
genes it is necessary to study a large contingent of patients 
belonging, if possible, the same ethnicity. A study evaluating 
the importance of mutations in the MUTYH to examine their 
prevalence in polish ethnicity found that among 1042 patients 
only 0.4% of the patients had a mutation biallelic associated 
with the development of adenomas and CRC15. Other authors 
by analyzing the contribution of mutations in germ MUTYH 
in the development of the CRC have evaluated 358 patients 
were not selected10. They found two patients (0.6%) with germ 
mutations biallelics and eight (2.2%) monoallelics mutations in 
the gene MUTYH. Patients with biallelic mutation had multiple 
adenomas, but not adenomatous polyposis profuse and, in both 
cases, the tumors were located in the distal colon. These results 
suggest that mutations biallelics of gene despite increasing 
the formation of adenomas and, consequently, the chance of 
developing cancer is likely to represent less than 3% of cases 
of sporadic CRC10. 
This study evaluated the expression of tissue several 
genes of the system BER and the ability to repair DNA of 
these genes by comparing normal tissue and neoplastic and 
correlating them with clinical variables and pathological32. The 
authors found that the expression of tissue gene OGG1 was 
significantly lower in tissues, neoplastic while the gene MUTYH 
showed no significant differences. They found that, to relate 
the expression of genes OGG1 and MUTYH when gender, age, 
location of the tumor histological grade stadiums of the TNM 
classification (I+II+x+II+IV) found no significant differences32. In 
Brazil, only one study evaluated the behavior of the gene OGG1 
in patients with sporadic CRC29. Using samples from the same 
population of patients the authors found a lower expression of 
OGG1 in tumoral tissue29. With regard to location of the tumor 
identified lower gene expression only in patients with cancer 
of the rectum and in tumors with more advanced stages29.
In the present study we found similar results. When 
evaluating the expression of OGG1 we found reduced expression 
in tumor tissue, similar to the studies previously cited32,29. 
We also found a reduction in the tissue expression of the 
gene in patients with tumors located in the rectum and in 
patients classified in more advanced stages of the disease. 
With respect to expression of the gene MUTYH, despite being 
lower in neoplastic tissue, we found no statistically significant 
differences (p=0.06). It is possible that these values could 
present significant differences if they were included a larger 
number of patients. When you relate gene expression MUTYH 
with variables selected for the present study found that there 
was less expression of the gene in tumors that had diameter 
greater than 3 cm, in presenting angiolymphatic invasion and 
those classified in the more advanced stages (T3-T4) of the TNM 
classification.  These findings suggest that the lower expression 
in these patients may contribute to the worse prognosis of 
the disease, since it is related to variables that confer a worse 
prognosis of the disease.
When we consider the results of the present study, and 
having science that there is a higher degree of oxidative stress 
in tissues neoplastic, it is possible that the lower expression 
of genes OGG1 and MUTYH in tumor tissue, as well as in 
the variables related to a worse prognosis of the disease, 
may occur due to the accumulation epigenetic mutations or 
hypermethylation in these genes by reducing their capacity 
to repair and favoring the development of a phenotype more 
aggressive as shown above11. The hypermethylation of the 
promoter region of genes that make up the system BER has 
been found in a variety of tumors (thyroid, bladder, ovaries, 
the brain as well as in the CRC)18.
Considering that genes OGG1, MUTYH, PARP-1 and  XRCC1 
are part of the same repair system (BER) it is possible that the 
presence of polymorphisms in these genes may interfere with 
their tissue expression. Recent study evaluating the influence 
of the APE1 T2197G polymorphism (asp148Glu) showed that 
this alteration interferes in the expression of the genes of the 
BER system when comparing normal and neoplastic tissues. The 
results found in the present study not only confirm previous 
results but also reinforce the importance of repair integrity 
by excision of bases in the etiopathogenesis and progression 
of sporadic CRC. 
CONCLUSION
The MUTYH and OGG1 genes present downregulation 
in the more advanced stages of colorectal cancer.
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